ClinicalTrials.gg
CompletedNCT06388655Updated Apr 29, 2024

The Effect of the Mobile EEG-Neurofeedback in Healthy Child and Adolescent

An interventional study of mobile neurofeedback and sham mobile neurofeedback in Internet Addiction, sponsored by Daegu Catholic University Medical Center. Completed at 1 site in Korea, Republic of. Open to participants aged 8 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-29.

Sponsored by Daegu Catholic University Medical Center · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 4 years 10 months after the study started (first participant enrolled Jun 2019, registered Apr 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
61
Allocation
Randomized
Ages
8 Years to 15 Years
Sex
All
01

Study summary

The objective of this study was to ascertain the therapeutic impact of mobile neurofeedback (MNF) in neurotypical children when compared to sham MNF. Clinical assessments were conducted both before and after the MNF intervention, and the effectiveness of the intervention was to be validated through these evaluations.

Read the detailed description

Neurotypical children aged 10-15 participated in the study. All subjects were assessed using the Kiddie Schedule for Affective Disorders and Schizophrenia Present and Lifetime Version Korean Version (K-SADS-PL-K) and confirmed to have no psychiatric symptoms. The participants were randomly assigned to the MNF active (N=31) or sham control (N=30) groups. The MNF program was administered using a mobile app (equipped with a headset with a 2-channel EEG sensor) for 30 min/day, 3 days/week, for 3 months. All participants and their parents completed self-report scales and participants complete neurocognitive function assessments including the continuous performance test, Stroop, children's color trails test-1 and 2, and intelligence test at baseline and after the 3-month MNF program.

02

Conditions studied

  • Internet Addiction

Keywords

  • mobile neurofeedback
  • neurotypical
  • internet addiction
03

In context

Internet Addiction Disorder

166 studies on the registry are indexed under Internet Addiction Disorder; 47 are open to participants now.

This study's enrollment of 61 is below the median of 88 across 96 interventional studies indexed under Internet Addiction Disorder.

Browse Internet Addiction Disorder studies →

Lead sponsor

Daegu Catholic University Medical Center is the lead sponsor of 28 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Child participants ranging from 8 to 15 years of age, who were recruited from the Department of Psychiatry at Daegu Catholic University Medical Center between 2019 and 2021

Exclusion criteria

Exclusion Criteria:

History of congenital genetic diseases History of brain damage History of neurological disorders History of psychiatric conditions such as schizophrenia spectrum disorder, autism spectrum disorder, obsessive-compulsive disorder, major depressive disorder, or bipolar disorder Participants with an IQ below 70, as determined by the Korean-Wechsler Intelligence Scale for Children-Fourth Edition (K-WISC-IV)

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
61 participants (actual)

Study arms

  • Experimental
    MNF active group

    In this study, neurofeedback headsets developed by OmniCNS were utilized, employing a dry EEG method to measure EEG signals at a rate of 250Hz. Signals were then transformed into the frequency domain through Fourier transform, allowing assessment of power across a wide range of frequencies. Feedback activities, like levitation or running, were based on attention levels determined by the Low beta + Middle beta / Theta Power ratio. Participants received training and engaged in neurofeedback games through the Omnifit Brain app using the provided headsets and personal smartphones for 12 weeks, three times a week for 10-20 minutes per session. Four game types based on the theta/beta ratio were offered, allowing participants to choose freely.

    Device: mobile neurofeedback

  • Sham comparator
    sham control group

    The sham neurofeedback was implemented through presenting randomized game outcomes, independent of real measurements. The scoring distribution was meticulously adjusted to achieve a realistic spectrum of results, prioritizing median scores to uphold uniformity in user experience.

    Device: sham mobile neurofeedback

Interventions

  • Devicemobile neurofeedback

    The participants were randomly assigned to the MNF active (N=31) or sham control (N=30) groups. The MNF program was administered using a mobile app (equipped with a headset with a 2-channel EEG sensor) for 30 min/day, 3 days/week, for 3 months.

  • Devicesham mobile neurofeedback

    The sham neurofeedback was implemented through presenting randomized game outcomes, independent of real measurements. The scoring distribution was meticulously adjusted to achieve a realistic spectrum of results, prioritizing median scores to uphold uniformity in user experience.

06

What researchers measure

Primary outcomes

  1. Comparisons of the means of children's self-scale variables

    Participants' condition regarding internet addiction, among other factors, was assessed using children's self-scales such as the Korea Internet Addiction Scale (K-scale).

    Time frame: through study completion, an average of 1 year

Secondary outcomes

  1. Comparisons of the means of parents' self-scale variables : Beck Depression Inventory-II (BDI-II)

    The evaluation of participants was conducted using parents' self-scales : Beck Depression Inventory-II (BDI-II)

    Time frame: through study completion, an average of 1 year

  2. Comparisons of the means of parents' self-scale variables : Beck Anxiety Inventory (BAI)

    The evaluation of participants was conducted using parents' self-scales : Beck Anxiety Inventory (BAI)

    Time frame: through study completion, an average of 1 year

  3. Comparisons of the means of children's K-WISC-IV(Korean Wechsler Intelligence Scale for Children-IV)

    Participants' intelligence levels were assessed using measures

    Time frame: through study completion, an average of 1 year

  4. Comparisons of the means of children's Stroop

    Participants' attention levels were assessed using measures

    Time frame: through study completion, an average of 1 year

  5. Comparisons of the means of children's ATA(Advanced Test of Attention)

    Participants' attention levels were assessed using measures

    Time frame: through study completion, an average of 1 year

  6. Comparisons of the means of children's CCTT(Children's Color Trails Test)

    Participants' attention levels were assessed using measures

    Time frame: through study completion, an average of 1 year

07

Study locations

1 site
  • Daegu Catholic University Medical Center
    Daegu, Nam-gu 42471, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06388655
Lead sponsor
Daegu Catholic University Medical Center
Responsible party
Junwon Kim (Clinical professor, Daegu Catholic University Medical Center) — Principal investigator
First posted
Apr 29, 2024
Start date
Jun 10, 2019
Primary completion
Jun 30, 2022
Completion
Jun 30, 2022
Last update
Apr 29, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion